國揚儀器股份有限公司

§ 植入式藥物持續釋出膠囊，買5送1，把握好時機

§ Cayman新產品：N-Cyclohexanecarbonyltetradecylamine, 13,14-dihydro-15-keto Prostaglandin J2, 及 9-Nitrooleate

§ Tocris 新產品

§ Dense-Array EEG & Epilepsy Symposium，9月30日於美國西雅圖(Seattle)舉行

長期穩定給藥
穩定維持體內藥物濃度
可植入動物不同部位
皮下.腹腔.血管.內臟部位皆可
腦內給藥灌流套組
手術技術光碟備索
檢索參考文獻齊全完備
www.alzet.com/bibliography

[回頁首]

Home page

New Products

N-Cyclohexane- carbonyltetradecylamine

13,14-dihydro-15-keto Prostaglandin J2

9-Nitrooleate

Welcome to Cayman Chemical's New Product Update!

The following products have been released by Cayman Chemical and are currently ready for delivery. To receive information on an individual product, simply click on the link below each item, or copy the URL into your web browser, and you will be sent directly to that item on our website!

Cayman Chemical has specials every month and every quarter.
http://www.caymanchem.com/promo/npu/specials

Featured Products:

| N-Cyclohexanecarbonyltetradecylamine | 10008317

N-Cyclohexanecarbonyltetradecylamine is an analog of N-cyclohexanecarbonylpentadecylamine, a selective inhibitor of acidic PEAase with an IC50 value of 4.5 µM, that contains 1 less carbon in the alkyl chain. The biological activity of N-cyclohexanecarbonyltetradecylamine has not been documented.
Full information...

| 13,14-dihydro-15-keto Prostaglandin J2 | 10008840

13,14-dihydro-15-keto PGJ2 is the dehydration product of 13,14-dihydro-15-keto PGD2 and is a presumed metabolite of PGJ2 via the 15-hydroxy PG dehydrogenase pathway. There are no published studies of the pharmacological properties or the formation of 13,14-dihydro-15-keto PGJ2 in vivo.
Full information...

| 9-Nitrooleate | 10008042

9-Nitrooleic acid is one of two regioisomers of nitrooleic acid, the other being 10-nitrooleic acid (OA-NO2; used for the mixture of isomers), which are formed by nitration of oleic acid in approximately equal proportions in vivo.
Full information...

Thank you for taking the time to review our latest products.

Please do not hesitate to contact us at 1-800-364-9897 or via email at [email-masked] if you have any questions about these exciting new items.

(C) 2006 Cayman Chemical

toll free 800.364.9897

direct dial 734.971.3335

[回頁首]

Search
new products via
our on-line catalog

Request
a catalog and other
technical resources

Contact
customer service
technical support

Send
this email
to a colleague

Suggest
new products
and ideas

Key new products from Tocris this month include:

VUF 5681
Potent H3 receptor silent antagonist

MRS 2279
Selective, high affinity P2Y1 antagonist

PNU 120596
Positive allosteric modulator of a7 nAChR

DR 2313
Potent PARP inhibitor

Xaliproden
Orally active, high affinity 5-HT1A agonist

Find all NEW products in your research area

Unsubscribe from e-Updates
View Privacy Policy
Tocris Bioscience
16144 Westwoods Business Park, Ellisville, MO 63021

Neuroscience 2006
Atlanta, GA
October 14-18, 2006

Cell Biology 2006
San Diego, CA
December 9-13, 2006
Booth Number: 1035 & 1037

More Conferences

[回頁首]

Dense-Array EEG &
Epilepsy Symposium

September 30, 2006
7:45 a.m.—3:30 p.m.

Harborview Medical Center
Research and Training Auditorium
325 9th Avenue
Seattle, Washington

Who Should Attend
Neurologists, epileptologists, neurosurgeons, and
EEG technologists.

Course Description
The objective of this course is to provide information
on new approaches for evaluating patients with
epilepsy using dense-array (256-channel) EEG.
Dense-array EEG enhances the spatial resolution
of scalp EEG. The speakers will describe how this
method, when used in conjunction with realistic
head models and EEG source analysis, may improve
our understanding of the nature of epileptic seizures
and epilepsy syndromes through a noninvasive
assessment of specifi c cortical circuits. The speakers
will also speculate on how the new information
derived from dense-array EEG may one day affect
epilepsy management.

Accreditation
The University of Washington (UW) School of
Medicine is accredited by the Accreditation Council
for Continuing Medical Education to provide
continuing medical education (CME) for physicians
and allied health technicians.
A fee is being assessed for CME credit. Certifi cates
will be provided for eligible physicians and allied
health technicians.

Fees and Registration
Physician’s fee: $35 without CME credit;
$90 with CME credit.
Allied health technician’s fee: $35 without CME credit;
$70 with CME credit.
The fee for this course includes catering and all
instructional materials. To ensure enrollment, please
complete the enclosed registration form and forward
it with the appropriate tuition. Driving and parking
instructions will be included with your registration
materials.

Course Objectives
At the conclusion of this activity, participants should
be able to:
• Describe the neurophysiological basis of epileptic
seizures.
• Discuss the rationale for dense-array EEG
recording.
• Describe how interictal dense-array EEG
recordings may affect epilepsy management.
• Explain the initial results of long-term EEG–video
monitoring with dense-array EEG.
• Discuss what dense-array EEG means from a
neurosurgical perspective.
• Utilize “hands-on” experience to apply the densearray
net of electrodes and to navigate the software
for data acquisition and analysis.

Accommodations
Silver Cloud Hotel Broadway
1100 Broadway
Seattle, WA 98122-4202
(206) 325-1400 or (800) 590-1801

Cancellation Policy
The organizers must receive written notifi cation
of your cancellation. A $35.00 processing fee will
be deducted from refund requests received before
the date of the course. No refunds will be issued
following the date of the course. The organizers
reserve the right to cancel this course 21 days prior
to the course date if a minimum enrollment is not
met or for other reasons that prevent the course
from being held. In such a case, each registrant
will be notifi ed by telephone, followed by written
notifi cation and a full refund. The University of
Washington is not responsible for any other costs
incurred, such as nonrefundable airline tickets or
hotel penalties.

[回頁首]

|